A new and exciting way to identify biomarkers, liquid biopsies are blood tests. In the past, some lung cancer patients could not take advantage of the latest discoveries in personalized medicine because there was not enough tissue to do biomarker testing. With FDA approval of the first liquid biopsy in 2016 and advances in research, specific genetic drivers, or suspected drivers, can be detected in more than half of lung cancers.
Hope With Answers Video Series: Liquid Biopsy
Dr. Greg Riely of Memorial Sloan Kettering Cancer Center discusses the basics of liquid biopsy for lung cancer with patient and advocate Lisa Goldman. Patient and advocate Lysa Buonanno discusses the most in-depth information surrounding liquid biopsy for lung cancer with Dr. Greg Riely of Memorial Sloan Kettering Cancer Center.